• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对爱泼斯坦-巴尔病毒潜伏复制因子EBNA1的小干扰RNA可抑制其功能以及EBV依赖的肿瘤细胞的生长。

siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells.

作者信息

Yin Qinyan, Flemington Erik K

机构信息

Tulane Health Sciences Center and Tulane Cancer Center, Department of Pathology, SL79, 1430 Tulane Avenue, New Orleans, LA 70112, USA.

出版信息

Virology. 2006 Mar 15;346(2):385-93. doi: 10.1016/j.virol.2005.11.021. Epub 2005 Dec 15.

DOI:10.1016/j.virol.2005.11.021
PMID:16343579
Abstract

The Epstein Barr virus (EBV) plays a role in maintenance of the tumor phenotype in a number of human cancers. The EBV latency replication factor, EBNA1, is required for persistence of the EBV episome, is anti-apoptotic, and is universally expressed in all EBV-associated tumors. Here, we show that EBNA1-specific siRNAs can inhibit EBNA1 expression and function. siRNAs were generated against three target sites in the EBNA1 messenger RNA, and two of these were found to inhibit EBNA1 expression from an ectopic EBNA1 expression cassette. EBNA1 siRNAs also inhibit endogenously expressed EBNA1 in EBV-positive epithelial and B-cell lines. Using a mini-EBV replication model, siRNA-mediated inhibition of EBNA1 expression suppressed the episomal maintenance function of EBNA1. Lastly, introduction of an EBNA1 siRNA into an EBV-positive tumor cell line inhibited tumor cell growth/survival. These data suggest that siRNAs against EBNA1 may have therapeutic value in EBV-associated diseases.

摘要

爱泼斯坦-巴尔病毒(EBV)在多种人类癌症的肿瘤表型维持中发挥作用。EBV潜伏复制因子EBNA1是EBV附加体持续存在所必需的,具有抗凋亡作用,且在所有EBV相关肿瘤中均普遍表达。在此,我们表明针对EBNA1的小干扰RNA(siRNA)可抑制EBNA1的表达和功能。针对EBNA1信使RNA中的三个靶位点生成了siRNA,其中两个被发现可抑制来自异位EBNA1表达盒的EBNA1表达。EBNA1 siRNA还可抑制EBV阳性上皮细胞系和B细胞系中内源性表达的EBNA1。使用微型EBV复制模型,siRNA介导的EBNA1表达抑制作用抑制了EBNA1的附加体维持功能。最后,将EBNA1 siRNA导入EBV阳性肿瘤细胞系可抑制肿瘤细胞的生长/存活。这些数据表明,针对EBNA1的siRNA可能在EBV相关疾病中具有治疗价值。

相似文献

1
siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells.针对爱泼斯坦-巴尔病毒潜伏复制因子EBNA1的小干扰RNA可抑制其功能以及EBV依赖的肿瘤细胞的生长。
Virology. 2006 Mar 15;346(2):385-93. doi: 10.1016/j.virol.2005.11.021. Epub 2005 Dec 15.
2
B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.B细胞特异性转录激活因子PAX5招募p300以支持EBNA1驱动的转录。
J Virol. 2020 Mar 17;94(7). doi: 10.1128/JVI.02028-19.
3
Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.鉴定MEF2B、EBF1和IL6R为EB病毒(EBV)核抗原1的直接基因靶点,这些靶点对EBV感染的B淋巴细胞存活至关重要。
J Virol. 2015 Oct 14;90(1):345-55. doi: 10.1128/JVI.02318-15. Print 2016 Jan 1.
4
Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells.通过RNA干扰抑制爱泼斯坦-巴尔核抗原1(EBNA1)可抑制EB病毒阳性伯基特淋巴瘤细胞的增殖。
J Cancer Res Clin Oncol. 2006 Jan;132(1):1-8. doi: 10.1007/s00432-005-0036-x. Epub 2005 Sep 23.
5
Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.黄芩素通过抑制 EBNA1 Q 启动子活性抑制 Epstein-Barr 病毒阳性鼻咽癌细胞生长。
Biomed Pharmacother. 2018 Jun;102:1003-1014. doi: 10.1016/j.biopha.2018.03.114. Epub 2018 Apr 5.
6
Regulation of Epstein-Barr virus OriP replication by poly(ADP-ribose) polymerase 1.聚(ADP-核糖)聚合酶 1 调控 Epstein-Barr 病毒 OriP 复制。
J Virol. 2010 May;84(10):4988-97. doi: 10.1128/JVI.02333-09. Epub 2010 Mar 10.
7
Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.EB病毒游离体维持中EBNA1六聚体环的结构与功能基础
J Virol. 2017 Sep 12;91(19). doi: 10.1128/JVI.01046-17. Print 2017 Oct 1.
8
Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.EBNA1的癌风险变体可解除爱泼斯坦-巴尔病毒游离体潜伏期的调控。
Oncotarget. 2017 Jan 31;8(5):7248-7264. doi: 10.18632/oncotarget.14540.
9
Epstein-Barr virus nuclear antigen 1 (EBNA1) induced cytotoxicity in epithelial cells is associated with EBNA1 degradation and processing.爱泼斯坦-巴尔病毒核抗原1(EBNA1)在上皮细胞中诱导的细胞毒性与EBNA1的降解和加工有关。
Virology. 2003 Sep 1;313(2):663-76. doi: 10.1016/s0042-6822(03)00392-1.
10
Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.EBNA1 显性负突变体在 EBV 感染的急性期独立于病毒基因组的快速丢失抑制 EBNA1 介导的转化基因表达。
Cancer Sci. 2010 Apr;101(4):876-81. doi: 10.1111/j.1349-7006.2009.01474.x. Epub 2009 Dec 16.

引用本文的文献

1
CRISPR/Cas13-Mediated Inhibition of EBNA1 for Suppression of Epstein-Barr Virus Transcripts and DNA Load in Nasopharyngeal Carcinoma Cells.CRISPR/Cas13介导的EBNA1抑制对鼻咽癌细胞中EB病毒转录本和DNA载量的抑制作用
Viruses. 2025 Jun 26;17(7):899. doi: 10.3390/v17070899.
2
EBV Latency Programs: Molecular and Epigenetic Regulation and Its Role in Disease Pathogenesis.EBV潜伏程序:分子与表观遗传调控及其在疾病发病机制中的作用
J Med Virol. 2025 Jul;97(7):e70501. doi: 10.1002/jmv.70501.
3
The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis.
针对多发性硬化症中潜伏性和裂解性爱泼斯坦-巴尔病毒感染的理由。
Brain. 2025 Sep 3;148(9):3057-3071. doi: 10.1093/brain/awaf170.
4
Interplay of aurora kinase a functional residues and Epstein-barr Nuclear Antigen 1 in Epstein-barr virus associated Gastric cancer using AGS cells.利用AGS细胞研究极光激酶a功能残基与爱泼斯坦-巴尔核抗原1在爱泼斯坦-巴尔病毒相关胃癌中的相互作用
BMC Cancer. 2025 Jan 24;25(1):143. doi: 10.1186/s12885-024-13260-z.
5
First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies.小分子EBNA1抑制剂VK-2019在爱泼斯坦-巴尔病毒阳性鼻咽癌患者中的首次人体临床试验及药代动力学和药效学研究
Clin Cancer Res. 2025 Mar 3;31(5):815-823. doi: 10.1158/1078-0432.CCR-24-2814.
6
USP7 Inhibitors Destabilize EBNA1 and Suppress Epstein-Barr Virus Tumorigenesis.USP7抑制剂使EBNA1不稳定并抑制爱泼斯坦-巴尔病毒的肿瘤发生。
J Med Virol. 2025 Jan;97(1):e70168. doi: 10.1002/jmv.70168.
7
A novel recombinant ORF7-siRNA delivered by flexible nano-liposomes inhibits varicella zoster virus infection.由柔性纳米脂质体递送的新型重组ORF7小干扰RNA可抑制水痘带状疱疹病毒感染。
Cell Biosci. 2023 Sep 12;13(1):167. doi: 10.1186/s13578-023-01108-1.
8
Comprehensive insight into altered host cell-signaling cascades upon Helicobacter pylori and Epstein-Barr virus infections in cancer.深入了解幽门螺杆菌和 Epstein-Barr 病毒感染引发的宿主细胞信号级联反应改变与癌症的关系。
Arch Microbiol. 2023 Jun 13;205(7):262. doi: 10.1007/s00203-023-03598-6.
9
SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target.鼻咽癌中的生长抑素受体2:与潜伏性EB病毒感染的关系及作为治疗靶点的潜力
Cancers (Basel). 2021 Sep 30;13(19):4944. doi: 10.3390/cancers13194944.
10
EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.EBNA1 抑制剂在 Epstein-Barr 病毒相关胃癌的异种移植模型中具有强大和选择性的抗肿瘤活性。
Gastric Cancer. 2021 Sep;24(5):1076-1088. doi: 10.1007/s10120-021-01193-6. Epub 2021 Apr 30.